Allergan, is a multi-specialty health care company focused on discovering, developing and commercializing innovative pharmaceuticals, biologics and medical devices that enable people to live good life.
Dublin, IE
Size (employees)
16,700 (est)-46%
Allergan was founded in 1948 and is headquartered in Dublin, IE
Report incorrect company information

Key People/Management at Allergan

Brenton Saunders

Brenton Saunders

Chairman, President and CEO, Allergan
William Meury

William Meury

EVP & Chief Commercial Officer
Matt Walsh

Matt Walsh

EVP & Chief Financial Officer
A. Bailey

A. Bailey

EVP & Chief Legal Officer and Corporate Secretary
Karen Ling

Karen Ling

EVP & Chief Human Resources Officer
C. Nicholson

C. Nicholson

EVP & Chief R&D Officer
Show more

Allergan Office Locations

Allergan has offices in Parsippany-Troy Hills and Dublin
Parsippany-Troy Hills, US
400 Interpace Pkwy
Show all (2)
Report incorrect company information

Allergan Financials and Metrics

Allergan Financials


Market capitalization (25-May-2018)

52.2 b

Closing share price (25-May-2018)

Allergan's current market capitalization is $52.2 b.
USDFY, 2013FY, 2014


3 b4.9 b

Accounts Receivable

883.3 m914.5 m


285.3 m296 m

Current Assets

5.3 b6.9 b
USDQ1, 2018

Current Liabilities

5.8 b

Total Equity

72.3 b
USDFY, 2013FY, 2014

Net Income

988.7 m1.5 b

Depreciation and Amortization

254.6 m248.1 m


(27 m)(44 m)

Accounts Payable

37.4 m1.9 m
Show all financial metrics

Allergan Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
Elastagen February 07, 2018$95 m
ZELTIQ Aesthetics (CoolSculpting) February 15, 2017$2.48 b
Report incorrect company information

Allergan News and Updates

Facial Aesthetics Market to grow at a CAGR of 8.05% including key players Allergan, Anika Therapeutics, Contura

HTF analysts forecast the Global facial aesthetics market to grow at a CAGR of 8.05% during the period 2018-2022. Posted via Industry Today. Follow us on Twitter @IndustryToday

Artificial Breasts Market to Make Great Impact in Near Future by 2025

Persistence Market Research has announced the addition of the “Artificial Breasts Market: Global Industry Analysis and Opportunity Assessment, 2017-2025 "report to their offering Posted via Industry Today. Follow us on Twitter @IndustryToday

Appaloosa gets permission for activist stance with Allergan stake

NEW YORK, May 17 (Reuters) - David Tepper's Appaloosa Management and two of his funds received Federal Trade Commission clearance earlier this week that could clear the way for the billionaire to become an activist investor in drugmaker Allergan Plc.

David Tepper now has the go-ahead to go full activist on Allergan if he wants to (AGN)

Noted activist investor David Tepper's hedge fund Appaloosa Management has received Federal Trade Commission antitrust clearance to increase its stake in Allergan.  Investors have been unhappy with Allergan's stock performance over the last year, and some would like to see the pharma company explo…
Show more
Report incorrect company information